Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03919552 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

StatusRecruiting
PhasePhase 3
Started2018-01-31
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 18, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2023-06-14
Study Identification, Study Status, Arms and Interventions v1
Primary completion date2023-01-31→2025-12-31
Completion date2023-06-30→2026-12-31
2019-04-14
Original filing
The purpose of this study is to compare cisplatin-based with carboplatin-based chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma (NPC), in order to confirm the value of carboplatin-based chemoradiotherapy in NPC patients.
Trial Details
NCT Number NCT03919552
Lead Sponsor Nanfang Hospital, Southern Medical University
Conditions Cisplatin, Carboplatin, NPC
Enrollment 482 participants
Start Date 2018-01-31
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-06-18